Floatz logo

Ketorolac Tromethamine

Hematological Malignancy (Leukemia- Lymphoma)

City of Hope Medical CenterPhase 4 / ApprovedDormant
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Hematological Malignancy (Leukemia- Lymphoma) cohort.

Asset / SponsorPhaseRating
FENTANYL
City of Hope Medical Center
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Mansoura University
Phase 4BB
gt719
Grit Biotechnology
Phase 1/2CCC

Same molecule, other indications

Ketorolac Tromethamine is also rated in:

migraine disorderDormant
BBB
Indicative ·
72 / 100
View asset →
breast cancerDormant
BB
Indicative ·
66 / 100
View asset →
Pain, PostoperativeDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →